Product descriptions

Varenicline is an oral anti-smoking supplement. Varenicline is the world's first partial efficacy drug for nicotine receptors, and it has a pharmacological difference from previous anti-smoking supplements such as nicotine gum, bupropion, and nicotine replacement drugs. In the United States, it is sold under the trade name Chantix domestically and in Asia.

Effecacy/Effectiveness 

The greatest effect of using varenicline is that even if you smoke during smoking cessation treatment, you will not get satisfaction.

The effect of varenicline is to lightly stimulate nicotine receptors and release a small amount of dopamine, effectively suppressing symptoms of departure or smoking impulses following smoking cessation.

Usage/Capacity

Smoking period 1 to 3 days : 0.5 mg once 4 days to 7 days : 0.5 mg twice

Non-smoking period 8 days to 12 weeks or more: 1mg twice

Precautions for use 

According to the U.S. Food and Drug Administration's (FDA) safety report, aggressive and unusual behavior and short-term memory loss are reported as interactions with alcohol, adding care to reduce the risk until a stability assessment is made.

Like the bupropion-based anti-smoking drug "wellbutrin," if you experience psychiatric symptoms such as depression or suicidal thoughts, you should immediately stop taking it and consult your doctor.

Manufacturer 

Tripada Healthcare Pvt ltd